ConductScience.org, home

Paper385502

Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.

Van Dijk WC and 4 others. Infect Immun, 1979. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization. Papers, record 385502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/385502

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
PubMed
Journal
Infect Immun
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
2.36
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Dijk WCW C
2Verbrugh HAH A
3van der Tol MEM E
4Peters RR
5Verhoef JJ

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, BacterialMajor topic
Complement ActivationMajor topic
Escherichia coliMajor topic
NeutrophilsMajor topic
PhagocytosisMajor topic
Complement C3
Hot Temperature
Humans
Opsonin Proteins
Polysaccharides, Bacterial

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
170410Protective capacity of antibodies against Escherichia coli and K antigens.Infect Immun1977https://conductscience.org/library/papers/70410PubMed
221849Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.Infect Immun1977https://conductscience.org/library/papers/21849PubMed
3415969Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.Immunology1977https://conductscience.org/library/papers/415969PubMed
4408268Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota.Infect Immun1977https://conductscience.org/library/papers/408268PubMed
5374636Virulence of Escherichia coli K1 in adults.J Infect Dis1979https://conductscience.org/library/papers/374636PubMed
6372531Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.J Med Microbiol1979https://conductscience.org/library/papers/372531PubMed
7363940Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.J Immunol1978https://conductscience.org/library/papers/363940PubMed
8344340Quantitative fluorescent immunoassay of antibodies to, and surface antigens of, Actinomyces viscosus.J Clin Microbiol1978https://conductscience.org/library/papers/344340PubMed
9318670Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).J Immunol1977https://conductscience.org/library/papers/318670PubMed
10670409Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes.J Clin Pathol1978https://conductscience.org/library/papers/670409PubMed
11839081Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.J Immunol Methods1977https://conductscience.org/library/papers/839081PubMed
12792409Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.J Pediatr1976https://conductscience.org/library/papers/792409PubMed
135543727Opsonic activity of agammaglobulinemic human sera.J Immunol1971https://conductscience.org/library/papers/5543727PubMed
144136144Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis.Lancet1974https://conductscience.org/library/papers/4136144PubMed
154133095Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.N Engl J Med1974https://conductscience.org/library/papers/4133095PubMed
164100434K antigens of Escherichia coli and renal involvement in urinary-tract infections.Lancet1971https://conductscience.org/library/papers/4100434PubMed
174181833The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.J Exp Med1969https://conductscience.org/library/papers/4181833PubMed
184176223Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.J Exp Med1968https://conductscience.org/library/papers/4176223PubMed
194152919Influence of the alternate complement pathway in opsonization of several bacterial species.Infect Immun1974https://conductscience.org/library/papers/4152919PubMed
204624675Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.J Immunol1972https://conductscience.org/library/papers/4624675PubMed

See all 33 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
42517219Prevalence of bovine endometritis, virulence mechanisms of Escherichia coli, and current therapeutic strategies: A review.Virulence2026https://conductscience.org/library/papers/42517219PubMed
41600967The Bacterial Swiss Army Knife: ExPEC Utilizes Multiple Resistance Mechanisms to Counteract Host Immune Responses.Vaccines (Basel)2025https://conductscience.org/library/papers/41600967PubMed
39833704Combatting Salmonella: a focus on antimicrobial resistance and the need for effective vaccination.BMC Infect Dis2025https://conductscience.org/library/papers/39833704PubMed
36468184A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein.EMBO Mol Med2023https://conductscience.org/library/papers/36468184PubMed
34832511Extraintestinal Pathogenic Escherichia coli: Virulence Factors and Antibiotic Resistance.Pathogens2021https://conductscience.org/library/papers/34832511PubMed
34447388CRP Enhances the Innate Killing Mechanisms Phagocytosis and ROS Formation in a Conformation and Complement-Dependent Manner.Front Immunol2021https://conductscience.org/library/papers/34447388PubMed
28611405Local immunization impacts the response of dairy cows to Escherichia coli mastitis.Sci Rep2017https://conductscience.org/library/papers/28611405PubMed
21098104The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi.Infect Immun2011https://conductscience.org/library/papers/21098104PubMed
20566606Procession to pediatric bacteremia and sepsis: covert operations and failures in diplomacy.Pediatrics2010https://conductscience.org/library/papers/20566606PubMed
18482721Origins and virulence mechanisms of uropathogenic Escherichia coli.Exp Mol Pathol2008https://conductscience.org/library/papers/18482721PubMed
8751904Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin.Infect Immun1996https://conductscience.org/library/papers/8751904PubMed
8153871Complement resistance in microbes.Springer Semin Immunopathol1994https://conductscience.org/library/papers/8153871PubMed
7014607Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types.J Clin Microbiol1980https://conductscience.org/library/papers/7014607PubMed
6389349Inhibition of phagocytosis and chemiluminescence in human leukocytes by a lipid soluble factor in normal tissues.Infect Immun1984https://conductscience.org/library/papers/6389349PubMed
6354922Opsonization of various capsular (K) E. coli by the alternative complement pathway.Immunology1983https://conductscience.org/library/papers/6354922PubMed
6341228Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.Infect Immun1983https://conductscience.org/library/papers/6341228PubMed
6339405Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.Infect Immun1983https://conductscience.org/library/papers/6339405PubMed
3980045Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.Immunology1985https://conductscience.org/library/papers/3980045PubMed
3521068Modulation of phagocytic cell function.Vet Res Commun1986https://conductscience.org/library/papers/3521068PubMed
3519464Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.Infect Immun1986https://conductscience.org/library/papers/3519464PubMed

See all 30 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C3718PubTator's text mininghttps://conductscience.org/library/genes/718

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/385502

GET https://conductscience.org/api/papers/v1/385502/references?page=2